Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
62
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

Tiffany W Chow1 Division of Neurology, Baycrest;2 Department of Psychiatry, Baycrest;3 Rotman Research Institute, Baycrest;4 Department of Psychiatry, Division of Neurology, University of Toronto;5 Department of Medicine, Division of Neurology, University of Toronto;6 Centre for Addiction and Mental Health PET CentreCorrespondence[email protected]
,
Ariel Graff-Guerrero4 Department of Psychiatry, Division of Neurology, University of Toronto;6 Centre for Addiction and Mental Health PET Centre
,
Nicolaas PLG Verhoeff2 Department of Psychiatry, Baycrest;3 Rotman Research Institute, Baycrest;4 Department of Psychiatry, Division of Neurology, University of Toronto;7 Kunin-Lunenfeld Applied Research Unit, Baycrest
,
Malcolm A Binns3 Rotman Research Institute, Baycrest;8 Dalla Lana School of Public Health, University of Toronto
,
David F Tang-Wai5 Department of Medicine, Division of Neurology, University of Toronto;9 University Health Network Memory Clinic
,
Morris Freedman1 Division of Neurology, Baycrest;3 Rotman Research Institute, Baycrest;5 Department of Medicine, Division of Neurology, University of Toronto
,
Mario Masellis5 Department of Medicine, Division of Neurology, University of Toronto;10 LC Campbell Cognitive Neurology Research Unit, Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, Toronto, ON, Canada
,
Sandra E Black3 Rotman Research Institute, Baycrest;5 Department of Medicine, Division of Neurology, University of Toronto;10 LC Campbell Cognitive Neurology Research Unit, Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, Toronto, ON, Canada
,
Alan A Wilson4 Department of Psychiatry, Division of Neurology, University of Toronto;6 Centre for Addiction and Mental Health PET Centre
,
Sylvain Houle4 Department of Psychiatry, Division of Neurology, University of Toronto;6 Centre for Addiction and Mental Health PET Centre
&
Bruce G Pollock4 Department of Psychiatry, Division of Neurology, University of Toronto;6 Centre for Addiction and Mental Health PET Centre
 show all
Pages 415-424 | Published online: 13 Jul 2011

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lina Riedl, Ian R Mackenzie, Hans Förstl, Alexander Kurz & Janine Diehl-Schmid. (2014) Frontotemporal lobar degeneration: current perspectives. Neuropsychiatric Disease and Treatment 10, pages 297-310.
Read now
Michael Tocco, Kathryn Bayles, Oscar L. Lopez, Robert K. Hofbauer, Vojislav Pejović, Michael L. Miller & Judith Saxton. (2014) Effects of memantine treatment on language abilities and functional communication: A review of data. Aphasiology 28:2, pages 236-257.
Read now
Kira A. Links, Sandra E. Black, Ariel Graff-Guerrero, Alan A. Wilson, Sylvain Houle, Bruce G. Pollock & Tiffany W. Chow. (2013) A case of apathy due to frontotemporal dementia responsive to memantine. Neurocase 19:3, pages 256-261.
Read now

Articles from other publishers (16)

Helmut Hildebrandt. 2021. Neuropsychological Tools for Dementia. Neuropsychological Tools for Dementia 249 302 .
Fransje E. Reesink, Gilles N. Stormezand, Rudi A. J. O. Dierckx & Peter Paul De Deyn. 2021. PET and SPECT in Neurology. PET and SPECT in Neurology 469 490 .
Maria Ricci, Andrea Cimini, Agostino Chiaravalloti, Luca Filippi & Orazio Schillaci. (2020) Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia. International Journal of Molecular Sciences 21:20, pages 7481.
Crossref
PAN LI, WEI QUAN, YU-YING ZHOU, YAN WANG, HUI-HONG ZHANG & SHUAI LIU. (2016) Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial. Experimental and Therapeutic Medicine 12:1, pages 492-498.
Crossref
Jutta Maria Birkhoff, Cesare Garberi & Laura Re. (2016) The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report. International Journal of Law and Psychiatry 47, pages 157-163.
Crossref
Chad M. VanDenBerg & Michael W. Jann. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents 329 349 .
Kevin T Ong, Shirantha G Adikari & Edward Strivens. (2014) Towards more rational prescribing of anti-dementia drugs. Australian & New Zealand Journal of Psychiatry 49:3, pages 295-296.
Crossref
Fransje E. Reesink, Gilles N. Stormezand, Rudi A. J. O. Dierckx & Peter Paul De Deyn. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology 339 357 .
Tiffany W. Chow, David Fam, Ariel Graff-Guerrero, Nicolaas P. G. Verhoeff, David F. Tang-Wai, Mario Masellis, Sandra E. Black, Alan A. Wilson, Sylvain Houle & Bruce G. Pollock. (2013) Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study. International Journal of Geriatric Psychiatry 28:3, pages 319-325.
Crossref
Christian Habeck, Shannon Risacher, Grace J. Lee, M. Maria Glymour, Elizabeth Mormino, Shubhabrata Mukherjee, Sungeun Kim, Kwangsik Nho, Charles DeCarli, Andrew J. Saykin & Paul K. Crane. (2012) Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease. Brain Imaging and Behavior 6:4, pages 568-583.
Crossref
Rachel E. Seltman & Brandy R. Matthews. (2012) Frontotemporal Lobar Degeneration. CNS Drugs 26:10, pages 841-870.
Crossref
Masood Manoochehri & Edward D. Huey. (2012) Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia. Current Neurology and Neuroscience Reports 12:5, pages 528-536.
Crossref
Tarik Karakaya, Fabian Fußer, David Prvulovic & Harald Hampel. (2012) Treatment Options for Tauopathies. Current Treatment Options in Neurology 14:2, pages 126-136.
Crossref
S. Hsieh, J.R. Hodges, C.E. Leyton & E. Mioshi. (2012) Longitudinal Changes in Primary Progressive Aphasias: Differences in Cognitive and Dementia Staging Measures. Dementia and Geriatric Cognitive Disorders 34:2, pages 135-141.
Crossref
Isabella Heuser & Hans Förstl. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 713 731 .
Rüdiger Hardeland. (2011) Cognitive Enhancers in Moderate to Severe Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6344.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.